Companies: 10,795·Total market cap: $144.5T
Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc.

OBIONASDAQHealthcare● Active
$3.95
+$0.05(+1.28%)
Market Cap$236528824
P/E Ratio—
52W High$5.424
52W Low$2.2
SEC Filings

Orchestra BioMed Holdings, Inc. (OBIO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001814114 · OBIO · NASDAQ · as of Jun 10, 2026

Filing snapshot

378
Total Filings
4
Latest Form
2026-06-02
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001814114 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-12
Fiscal Year End
Mar 12, 2026
Accession No.
0001104659-26-026754
Primary Document
obio-20251231x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001814114 · Accession 0001104659-26-026754

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-12
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2026-02-13Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
10-Q
2026-05-12
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-29
View
ARSARS
ARS
2026-04-29
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-29
View
DEF 14AProxy Statement
FORM DEF 14A
2026-04-29
View
10-KAnnual Report
10-K
2026-03-12
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-27
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-02-25
View
8-KCurrent Report
FORM 8-K
2026-02-13
View
S-8Employee Stock Plan Registration
FORM S-8
2026-02-06
View
S-8Employee Stock Plan Registration
FORM S-8
2026-02-06
View
8-KCurrent Report
FORM 8-K
2026-01-12
View
424B3424B3
424B3
2025-11-21
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2025-11-19
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-11-14
View
Showing 1–15 of 212 filingsForm 4 / 144 hidden· 378 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001814114  |  Exchange: NASDAQ · Healthcare

Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) has submitted 378 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001814114, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Orchestra BioMed Holdings, Inc.'s most comprehensive regulatory disclosure. The most recent Orchestra BioMed Holdings, Inc. 10-K was filed on 2026-03-12 for fiscal year ending 2026. Historical OBIO 10-K annual reports are available from 2020 through 2026.

Investors researching Orchestra BioMed Holdings, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
PRLD SEC Filings →ENTA SEC Filings →IVA SEC Filings →EPRX SEC Filings →CRBU SEC Filings →TARA SEC Filings →AVTX SEC Filings →IVVD SEC Filings →
→ OBIO Financials→ OBIO Earnings→ OBIO Insider Trades

Frequently Asked Questions

OBIO SEC Filings · 8 questions

Orchestra BioMed Holdings, Inc. (OBIO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 378 filings and access original documents at no cost. Orchestra BioMed Holdings, Inc.'s CIK is 0001814114.

OBIO SEC filingsOrchestra BioMed Holdings, Inc. SEC documentsfind OBIO 10-K